Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

AIM Admission and Directorate Changes

31 Aug 2011 08:00

RNS Number : 2708N
Silvermere Energy PLC
31 August 2011
 



 

31st August 2011

 

Silvermere Energy plc

("Silvermere" or "the Company")

 

AIM Admission and Directorate Changes

 

 

Silvermere Energy Plc ("Silvermere" or "the Company") is pleased to announce that, following shareholder approval granted on 30th August 2011, the Company has completed the acquisition of the Mustang Asset located in Kleberg County, Texas waters in the Gulf of Mexico and that dealings in the Company's Ordinary Shares and Pre-CVA Warrants have today commenced on AIM. Definitions in this announcement are as used in the Company's admission document dated 2 August 2011.

 

Accordingly, Andy Morrison, Frank Moxon and Stewart Dalby have been appointed to the board.

 

Andy Morrison has been appointed as Chief Executive. He has spent his entire career in the oil and gas industry, including Shell, BG and BOC, and from 2007 until 2010 was CEO of Xtract Energy plc. Frank Moxon is an experienced corporate financier specialising in natural resources and was previously head of corporate finance and head of natural resources at Williams de Broe, and has been appointed as non-executive Chairman. Stewart Dalby, who has over 40 years' experience of the oil and gas industry, has been appointed as a non-executive director; Bruce Evers, formerly executive chairman, remains on the board as a non-executive director. Reinhold Heus and John Roddison have stepped down from the Board, and the Company wishes to express its thanks for their service.

 

The Competent Person's Report produced by RPS Energy and included in the Company's admission document dated 2nd August 2011 assigns proven and probable reserves attributable to the Mustang Asset valued at approximately £18.35 million.

 

The Company's market capitalisation at admission at the placing price of 25p is approximately £4.25 million.

 

Under the guidance of the new Board, the Company intends to pursue a strategy of acquiring a portfolio of US oil and gas licence interests onshore and in shallow offshore waters, characterised by relatively low risk and low cost with the potential for near term production.

 

Chief Executive Andy Morrison said:

 

"We are delighted to have completed the acquisition of an interest in such a promising asset, which forms an excellent starting point for the Company in acquiring a portfolio of US oil and gas assets. We are committed to maximising the potential of the Mustang Asset and preparations for the tie-in of the I-1 Well are on track. We look forward to updating investors in due course."

 

In addition to the Company, the New Directors hold or have held the following directorships or are or have been partners in the following partnerships within the five years prior to the date of this document:

 

 

 

Andy Morrison

Current Directorships/Partnerships

Spinnaker Management Resources Ltd

 

Past Directorships/Partnerships

Xtract Energy plc Elko Energy Inc

Xtract International Limited Xtract Oil Ltd

Xtract Energy Holdings Ltd Xtract Energy Spain SA

Zhibek Resources Ltd Extrem Energy AS

Zhibek Oil and Gas Ltd Xtract Energy (Oil Shale) Morocco SA

 

Frank Moxon

Current Directorships/Partnerships

Chartered Institute for Securities & Investment Imperial Minerals plc

Cove Energy plc Imperial Minerals (UK) Limited

Diabetes UK Services Limited Reach Volunteering

Hoyt Moxon Ltd The British Diabetic Association

Hoyt Moxon Capital Ltd Whetstone Minerals Ltd

 

Past Directorships/Partnerships

London Energy Group Ltd Securities & Investment Institute

 

Stewart Dalby

Current Directorships/Partnerships

Oilbarrel.com Limited

 

Past Directorships/Partnerships

None

 

The holdings of the Directors in the Company are as follows:

 

Number of

Ordinary Shares

% of issued share capital

Placing Warrants

Options

Andy Morrison

67,920

0.40

67,920

200,000

Frank Moxon

144,000

0.85

144,000

200,000

Stewart Dalby

-

-

-

100,000

Bruce Evers

96,000

0.57

96,000

200,000

 

 

Save for the above, there is no further information required to be disclosed under paragraph (g) of Schedule 2 of the AIM Rules for Companies, with respect to the appointment of the New Directors.

 

 

ENDS

 

 

 

 

For further information please contact:

 

Silvermere Energy plc

Andy Morrison, Chief Executive

 

 

 

 

+44 (0)7980 878561

 

Merchant Securities Limited (Nominated Adviser and Broker)

Lindsay Mair/Virginia Bull

 

Rivington Street Corporate Finance Limited

Jon Levinson/Dru Edmonstone

 

Old Park Lane Capital

Luca Tenuta

 

 

+ 44(0)20 7628 2200 

 

 

+44 (0)20 7562 3357

 

+44 (0)20 7493 8188

Bishopgate Communications

Nick Rome/Shabnam Bashir

 

+44(0)20 7562 3350

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFFRTAIIVIL
Date   Source Headline
8th Jun 20267:00 amRNSNotice of AGM
29th May 20265:00 pmRNSTotal Voting Rights
26th May 20267:00 amRNSInvestment in Talking Medicines CLNs
22nd May 20267:00 amRNSDevice Authority Convertible Loan Notes Investment
19th May 20267:00 amRNSPlacing to raise £222,000
12th May 20267:00 amRNS-RDevice Authority Strategic Partnership
8th May 202612:53 pmRNSResult of GM & Update on Open Offer
8th May 20267:00 amRNSResults of Open Offer
21st Apr 20267:00 amRNSOpen Offer and Notice of General Meeting
31st Mar 20265:00 pmRNSTotal Voting Rights
5th Mar 20267:00 amRNSExtension of loan facility agreement
3rd Mar 20267:00 amRNSResults of Open Offer
13th Feb 20267:00 amRNSOpen Offer at 0.40p to raise up to £384,408
5th Feb 20267:00 amRNS-RTern Notes Automotive Momentum at Device Authority
15th Jan 20267:00 amRNSUpdate regarding SVV2
8th Jan 20267:00 amRNSInvestor Presentations
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
12th Dec 20257:00 amRNSIssue of Talking Medicines Convertible Loan Notes
28th Nov 20257:00 amRNSUpdate regarding capital commitment to SVV2
25th Nov 20257:00 amRNSTalking Medicines CLN Modifications
31st Oct 20253:35 pmRNSTotal Voting Rights
15th Oct 20257:00 amRNSResults of Open Offer
9th Oct 20257:00 amRNSRemuneration Reductions & Distribution Commitment
29th Sep 20257:00 amRNSOpen Offer to raise up to £642,486
15th Sep 20257:00 amRNSExtension of Loan Facility Term
4th Sep 20257:00 amRNSInterim results for the six months to 30 June 2025
1st Sep 20257:00 amRNSAppointment of shareholder relations adviser
31st Jul 20254:34 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults of underwritten Open Offer & TVR
24th Jul 20257:00 amRNSReceipt of Bridging Loan
14th Jul 20257:00 amRNSUnderwritten Open Offer to raise £642,486
30th Jun 202512:07 pmRNSResult of AGM
13th Jun 20257:00 amRNSDirector Share Purchase
11th Jun 20257:00 amRNSDirector Share Purchase
6th Jun 20257:00 amRNSNotice of AGM and Director Retirement
5th Jun 20257:00 amRNSResults for the year ended 31 December 2024
30th May 20255:39 pmRNSTotal Voting Rights
7th May 20257:00 amRNSResults of Underwritten Open Offer
24th Apr 20257:00 amRNSPurple Transform appointment
17th Apr 20257:00 amRNSUnderwritten Open Offer to raise £340,140
11th Mar 20257:00 amRNS-RDevice Authority Microsoft & CyberArk Partnership
11th Mar 20257:00 amRNS-RSure Ventures Update
28th Feb 20255:00 pmRNSTotal Voting Rights
21st Feb 20257:00 amRNSPlacing to raise £221,154
14th Jan 20257:30 amRNS-RProgressive Equity Research Report
10th Jan 20257:00 amRNSInvestor Presentations
2nd Jan 20257:00 amRNSInvestment in Sure Ventures plc
31st Dec 20241:30 pmRNSTotal Voting Rights
23rd Dec 202411:39 amRNSDevice Authority update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.